Specific-class Skin Side-effects of Drugs Might Compromise Blinding in Randomized Controlled Trials

Affiliations

• ¹ Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Paris, France; Department of Internal Medicine, Intercommunal Creteil Hospital, Créteil, France.
• ² Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; Department of Dermatology, Centre Hospitalier Régional Universitaire (CHRU) Tours, Tours, France. annabel.maruani@univ-tours.fr.
• ³ Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; Department of Dermatology, Centre Hospitalier Régional Universitaire (CHRU) Tours, Tours, France.
• ⁴ Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; INSERM CIC 1415, CHRU Tours, Tours, France.
• ⁵ Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Paris, France; Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France.